Famotidine
NDC 70954-316, Famotidine, powder, for suspension, from ANI Pharmaceuticals, Inc..
- Product NDC
- 70954-316
- Status
- Listed
- Labeler
- ANI Pharmaceuticals, Inc.
- Dosage form
- POWDER, FOR SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215043
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70954-316 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- FAMOTIDINE40 mg/5mL
Pharmacologic classes
Histamine H2 Receptor Antagonists [MoA]; Histamine-2 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70954-316-10 | 70954031610 | 50 mL in 1 BOTTLE (70954-316-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/8e41e259-b161-4f11-a6f7-14e6b60885b8NADAC price for package 70954031610
GET /v1/drugs/nadac/70954031610
Use it
Look up 70954-316 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70954-316 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70954-316. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.